OIS Weekly: Company/Market Watch – Ocuphire Pharma Reports Positive Top-line Results in the MIRA-2 Phase III Registration Trial Mar 24, 2021
Ocuphire Represented by Mina Sooch Participated in Crain’s Detroit's Event: “M&A Lessons from the Biggest Deals of 2020" Mar 10, 2021
